Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analyst target price upgrades dominated activity on July 8, with a broad sweep across technology, healthcare, and insurance names.
PANW saw the biggest consensus shift in tech. The average target price rose to $324 from $322. 43 analysts now cover the cybersecurity giant. Short interest sits at just 2.8% of free float — bears are not betting against it.
MCHP attracted target increases too. The average target climbed to $114 from $113. The chipmaker carries a $45.7 billion market cap. Short interest is modest at 7.9% of free float.
In equipment rental, URI received a target lift to $1,150 from $1,137. The stock has 17 buy-rated analysts behind it. That level of bullish consensus is hard to ignore.
Healthcare names also moved. EW, , and all received target upgrades. 's consensus target now stands at $258.59.
On the insurance side, UBS upgraded both MRSH and MET to Buy. UBS lifted the Marsh & McLennan target to $212. MetLife's new target stands at $105.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
